Executive Director

Mr. Guo Jiajun (郭珈均) is an executive Director and CEO of the company. He graduated from Shandong University at Weihai (山東大海威海分校) in 1998 with a bachelor degree of science with major in electronics and information systems and completed an international MBA program organized by the China Center for Economic Research at Peking University from 2005 to 2008, and was awarded a master degree of business administration by Fordham University of the US in 2008. He worked for the Housing Fund Management Centre of Weihai Finance Bureau in Shandong (山東省威海市住房公積金管理中心) as a staff member and was responsible for the management and payment of housing funds from 1998 to 2001. He was the manager of the administration department of Bloomage Investment, an investment holding company (the subsidiaries of which are principally engaged in property development and investments in the PRC as well as operation and management of stadium and commercial projects in the PRC). He is primarily responsible for the Group's strategic development and investment planning. He is also responsible for supervising the management team of the Group to implement and execute decisions of the Board. He joined the Group in March 2006.

Independent Non-executive Director

Ms. Zhan Lili (詹莉莉) was appointed as an independent non-executive Director on 1 September 2008. She completed her studies in business administration at the Faculty of Business Administration of Capital University of Economics and Business in 2003. Ms. Zhan was an assistant to the General Manager of Tomson (Shanghai) Company Limited (湯臣高爾夫(上海)有限公司) from 2000 to 2001, worked in the human resource department of the Beijing branch of Industrial Bank Co., Ltd. (興業銀行) from 2003 to 2007 and has been a president assistant of Beijing Hai Dian Science & Technology Development Co., Ltd. (北京海澱科技發展有限公司), a company engaged in investments in bio-technology and pharmaceuticals, electronics and information technology, environmental protection materials and property development, since 2007.

Senior Management

Ms. Liu Aihua (劉愛華) is the general manager of Freda Biochem. Ms. Liu graduated from the pharmaceutical department of Shenyang Pharmaceutical University in 1983 with a bachelor degree of science. Ms. Liu had worked for Jinan Yongning Pharmaceutical Ltd. during the period between August 1983 and August 1998 and was responsible for research and technical management. Before joining the Group, Ms. Liu was the vice-president of Biopharmaceuticals Research Institute during the period between July 1998 and December 2001. Ms. Liu has over 25 years' experience in both of pharmaceutical research and management. She joined the Group in January 2002.

Mr. Wang Chunxi (王春喜) is the vice general manager of Freda Biochem and the manager of production department of Freda Biochem. Mr. Wang graduated from East China University of Science & Technology with a bachelor degree in engineering and he was major in biochemistry engineering. Mr. Wang worked for the Biopharmaceuticals Research Institute for 10 years. He joined the Group in January 2000 as a chief of workshop.

Mr. Guo Xueping (郭學平) is the vice general manager and manager of the research and development department of Freda Biochem. Mr. Guo graduated from the pharmaceutical department of Shandong Medical University with master degree of science in 1987. Mr. Guo worked for Biopharmaceuticals Research Institute for 10 years before joining the Group in January 2000. Mr. Guo obtained the National Technology Advancement Third-Class Award awarded by the National Technology Committee (國家科學技術委員會) (which has been renamed as 科學技術部 (The Ministry of Science and Technology), an Independent Third Party, in 1995 for his research in the production of injection grade hyaluronic acid, the Great Achievement Award of the "Ninth five-years" National Key Technology Tackle Project in 2001 jointly organized by the Ministry of Science and Technology (科學技術部), Ministry of Finance (財政部), National Development and Planning Committee (國家發展計劃委員會) and State Economic and Trading Committee (國家經濟及貿易委員會), all being Independent Third Parties, for his research in "the production of hyaluronic acid pharmaceuticals by fermentation", and obtained the Wu Jie Ping Medical Research Award - Paul Janssen Pharmaceutical Research Award - Medical Production Third Class Award (吳階平醫學研究獎 - 保羅‧楊森藥學研究獎製藥工程專業三等獎) in 2002, which is an award established by International Health Exchange and Cooperation Centre of Ministry of Health (衛生部國際交流與合作中心) and a pharmaceutical enterprise to award the medical and pharmaceutical researches in the PRC, both being Independent Third Parties.

Mr. Zhang Xing (張興) is the chief financial officer of Freda Biochem, a qualified accountant of the Chinese Institute of Certified Public Accountants. Mr. Zhang worked as the project manager of Beijing Xiwen Certified Public Accountants during the period between 1998 and 2000 before joining the Group in January 2001. During his employment with Beijing Xiwen Certified Public Accountants, he was mainly responsible for auditing works, including liaising with clients on auditing tasks, inspecting relevant financial documents, resolving auditing issues and compiling audit reports.